Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...
AWS CEO Matt Garman talks AI impacts in 2025, tech innovation investments in silicon, cloud, storage, GenAI, AWS partners and ...
StockStory.org on MSN9h
Amplitude (AMPL) Shares Skyrocket, What You Need To KnowWhat Happened? Shares of data analytics software provider Amplitude (NASDAQ:AMPL) jumped 22.7% in the pre-market session after the company reported impressive fourth-quarter 2024 earnings: its sales ...
StockStory.org on MSN14h
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With EstimatesBiopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) in Q4 CY2024, but sales were flat year on year at $167.5 ...
Businesses can manage generative AI risks by enforcing governance, securing AI-generated content, reviewing AI-written code, ...
Microsoft has unveiled Muse and while the technology behind it is impressive, it's not clear how it will be useful to ...
ChatGPT developer OpenAI's weekly active users surged past 400 million in February, a company spokesperson told Reuters on ...
A.I. tools from Microsoft and other companies are helping write code, placing software engineers at the forefront of the ...
Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas.
According to an EY India report, Generative AI could boost productivity in India's retail sector by 35-37% over the next five years, with 48% of businesses already testing AI solutions. 14 Feb 25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results